The Valley Desk

NCT03644069 · Interventional trial

A Study of the Safety, Efficacy and Tolerability of Nexvax-2 in Patients With Celiac Disease (CeD)

Overall registry status Unknown

Phase 2

Conditions Autoimmune Diseases, Celiac, Celiac Disease, Digestive System Disease, Gastrointestinal Disease, Gluten Sensitivity, Intestinal Disease, Malabsorption Syndromes

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov